This site is secured using RapidSSL

Want to keep bowel cancer risk at bay?

Published on 26 November 2018  | Download | back to previous


This is an image from this news item. (click to view the video)Intake of aspirin and omega-3 is safe and effective at reducing chances of bowel cancer in high-risk patients, according to a new clinical trial. 

In the trial, published in the journal The Lancet, these low-cost drugs reduced the number of pre-cancerous polyps -- a small growth, usually benign -- in patients found to be at high risk of developing bowel cancer. 

The findings showed that patients who took aspirin had 22 per cent fewer polyps compared to those who took the placebo.

Although aspirin and EPA had beneficial effects on polyp numbers individually, the combination of aspirin and EPA together appeared to have an even greater effect, as it provided another layer of prevention, alongside colonoscopy, the researchers said. 

"The trial demonstrates that both aspirin and EPA have preventative effects, which is particularly exciting given that they are both relatively cheap and safe compounds to give to patients," said Mark Hull, Professor at the University of Leeds in the Uk.



An image from our site
Digestive Cancers Europe
Scots House
Scots Lane
Salisbury
SP1 3TR
United Kingdom
Tel: +44 1722 333 587
info@digestivecancers.eu


Youtube Facebook Facebook
Warning!!! Warning!!! Cookies are disabled Warning!!! Warning!!!